Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report

BACKGROUND: Nivolumab, a monoclonal antibody targeting the programmed death-1 receptor, is indicated in locally advanced or metastatic non-small cell lung cancer, with progression after platinum-based chemotherapy. Up-to-now, few data are available concerning brain activity of this treatment and con...

Descripción completa

Detalles Bibliográficos
Autores principales: Pluchart, Hélène, Pinsolle, Julian, Cohen, Julien, Ferretti, Gilbert R., Bedouch, Pierrick, Giaj Levra, Matteo, Toffart, Anne-Claire, Moro-Sibilot, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499003/
https://www.ncbi.nlm.nih.gov/pubmed/28679408
http://dx.doi.org/10.1186/s13256-017-1334-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499003/
https://www.ncbi.nlm.nih.gov/pubmed/28679408
http://dx.doi.org/10.1186/s13256-017-1334-z

Ejemplares similares